Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas

  title={Metachronous metastasis- and survival-analysis show prognostic importance of lymphadenectomy for colon carcinomas},
  author={Tilman Laubert and Jens K. Habermann and Claudia Hemmelmann and Markus Kleemann and Elisabeth Oevermann and Ralf Bouchard and Philipp Hildebrand and Thomas Jungbluth and Conny Georg B{\"u}rk and Hamed Esnaashari and Erik Schl{\"o}ricke and M. Hoffmann and Andreas Ziegler and Hans Peter Bruch and Uwe Johannes Roblick},
  journal={BMC Gastroenterology},
  pages={24 - 24}
BackgroundLymphadenectomy is performed to assess patient prognosis and to prevent metastasizing. Recently, it was questioned whether lymph node metastases were capable of metastasizing and therefore, if lymphadenectomy was still adequate. We evaluated whether the nodal status impacts on the occurrence of distant metastases by analyzing a highly selected cohort of colon cancer patients.Methods1,395 patients underwent surgery exclusively for colon cancer at the University of Lübeck between 01… 
Metachronous metastasis confined to isolated lymph node after curative treatment of colorectal cancer
It is suggested that multidisciplinary management is a potentially effective treatment strategy for isolated LNM and since time to LNM, the T-stage, and histological type are prognostic factors, an active follow-up program for colorectal cancer is required.
Patterns Of Metachronous Metastases After Curative Treatment Of Breast Cancer.
Aneuploidy and elevated CEA indicate an increased risk for metachronous metastasis in colorectal cancer
The data show that aneuploidy and elevated CEA levels besides increased T category could serve for individual risk assessment to predict metachronous metastases.
Evaluation of Relapse-Free Survival in T3N0 Colon Cancer: The Role of Chemotherapy, a Multicentric Retrospective Analysis
Data confirmed the role of known prognostic factors and suggest the relevance of adjuvant chemotherapy also in low-risk stage II T3N0 CC patients, however, the highest risk in high-risk subgroup should be identified to be submitted to AC.
Regional lymph node sampling in hepatoma resection: insight into prognosis.
Extended Lymphadenectomy in Colon Cancer is Crucial
Extended lymphadenectomy is oncologically relevant only when it is combined with removal of the primary tumor with adequate longitudinal clearance, an intact complete mesocolon, and high vascular tie.
Extended Lymphadenectomy in Colon Cancer Is Debatable
It is proposed that in light of the available published evidence, the role of radical lymphadenectomy is currently unproven, with large randomized clinical trials required in the future to determine whether there is a survival benefit for colon cancer patients.
Reduced risk of distant recurrence after adjuvant chemotherapy in patients with stage III colon cancer aged 75 years or older.
Distant recurrence risks at higher age definitely warrant consideration of adjuvant chemotherapy for elderly stage III colon cancer patients, and this decision should be based on a multidisciplinary and functional assessment of the patient, not on age.
Pan-metastatic cancer analysis of prognostic factors and a prognosis-based metastatic cancer classification system
A prognosis-based metastatic cancer classification system reflects the grade of malignancy in metastatic cancers and may guide the prediction of survival and individualized treatment and aid clinicians in properly allocating medical resources to metastatic patients.


Predictors of Distant Metastasis and Mortality in Patients with Stage II Colorectal Cancer
Clinical factors that predicted distant metastasis and mortality in patients with stage II colorectal cancer (CRC) were determined by a retrospective review of patients admitted to the Dallas Veteran's Affairs Medical Center from 1998 to 2002.
Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
Are lymph node micrometastases of any clinical significance in dukes stages A and B colorectal cancer?
Lymph node micrometastases are not a useful prognostic marker in Dukes Stages A and B and do not imply different strategies for additional therapy or follow-up.
Prognostic Significance of the Number of Lymph Nodes Examined in Colon Cancer Surgery: Clinical Application Beyond Simple Measurement
The clinical significance of NLNE is not limited to being a benchmark for quality care, but has a definite benefit as a prognostic indicator across the stages.
Hospital lymph node examination rates and survival after resection for colon cancer.
The number of lymph nodes hospitals examine following colectomy for colon cancer is not associated with staging, use of adjuvant chemotherapy, or patient survival, and efforts by payers and professional organizations to increase node examination rates may have limited value as a public health intervention.
Lymph node evaluation and survival after curative resection of colon cancer: systematic review.
The number of lymph nodes evaluated after surgical resection was positively associated with survival of patients with stage II and stage III colon cancer, and support consideration of the number ofymph nodes evaluated as a measure of the quality of colon cancer care.
Sentinel-node biopsy or nodal observation in melanoma.
The staging of intermediate-thickness primary melanomas according to the results of sentinel-node biopsy provides important prognostic information and identifies patients with nodal metastases whose survival can be prolonged by immediate lymphadenectomy.
Role of Lymphadenectomy in Surgical Treatment of Solid Tumors: An Update on the Clinical Data
An extensive literature review of recent reports indicates that lymphadenectomy does not improve overall survival and lymph node resection should be conceived in terms of staging, prognosis, and regional control only.
Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer.
The number ofnegative nodes is an important independent prognostic factor for patients with stage IIIB and IIIC colon cancer and a higher number of negative nodes was found to be independently associated with improved disease-specific survival.
Association of family history with cancer recurrence and survival among patients with stage III colon cancer.
Among patients with stage III colon cancer receiving adjuvant chemotherapy, a family history of colorectal cancer is associated with a significant reduction in cancer recurrence and death.